Research programme: fluoroquinolones - Kyorin

Drug Profile

Research programme: fluoroquinolones - Kyorin

Alternative Names: AM-1939; AM-1954; Compound 21

Latest Information Update: 09 Jul 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Kyorin Pharmaceutical
  • Class Fluoroquinolones
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Preclinical Bacterial infections

Most Recent Events

  • 09 Jul 2008 Preclinical development is ongoing
  • 03 Oct 2007 Preclinical trials in Bacterial infections in Japan (unspecified route)
  • 20 Sep 2007 Data presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC-2007) added to the Bacterial Infections antimicrobial activity and pharmacodynamics sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top